Delivery Order SPE2DB24D1007-SPE2DB25FCCEG

Award Date 6/16/25
Potential Completion Date 6/17/25
Potential Value $26K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Trelegy Ellipta 200-62.5-25 60S, a pharmaceutical product, with a ceiling value of $1,843.42 and a completion date of June 26, 2025. The contract is a firm fixed-price delivery order and is not set aside for any small business program. AmerisourceBergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trelegy Ellipta (100-62.5-25) inhalation product. The order is valued at $3,922.33 and has an ultimate completion date of September 6, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Trelegy Ellipta 200-62.5-25 60S medication. The contract has a firm fixed price, a ceiling value of $39,634.48, and an ultimate completion date of May 8, 2025. The contract is not set aside and represents an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,877.88, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract is a firm fixed price, non-set-aside award with a completion date of June 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $7,214.80 and a period of performance through March 6, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $24,835.26. The contract is a firm fixed-price, non-set-aside delivery order with a period of performance through April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products, with a ceiling value of $24,634.02 and an ultimate completion date of December 21, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,896.70 firm fixed-price contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products. The contract has an ultimate completion date of May 20, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a total ceiling value of $8,165.41. The contract is a firm fixed-price delivery order, with a completion date of June 12, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a firm fixed price ceiling value of $32,928.42. The contract has an ultimate completion date of May 19, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FCCEG
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $26,058.50 and a completion date of June 17, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 9/15/25, 9:54 AM